Summary of Purpose
To determine complete recanalization, early clinical recovery rates, and safety of continuous monitoring in patients treated with 2 Mhz transcranial Doppler (TCD) used in conjuction with tissue plasminogen activator (tPA) in patients with acute ischemic stroke.Read More →
The following dates are available for this trial. Trial information last updated on 5 August 2008.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- A2207s, Genetech, Inc.
Prospective, randomized, multi-center clinical trial.